Abera Bioscience AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.04	23.49	6.09	3.32	15.43	11.95
Cash & Short-Term Investments	26.04	23.49	6.09	3.32	15.43	11.95
Cash Growth	373.39%	285.70%	83.49%	-78.50%	29.13%	1224.40%
Other Receivables	1.4	0.99	0.65	0.77	0.77	0.3
Receivables	1.4	0.99	0.65	0.77	0.77	0.3
Prepaid Expenses	0.48	0.9	3.91	3.38	1.49	0.19
Other Current Assets	-	-	-	-	-0	-
Total Current Assets	27.92	25.37	10.65	7.46	17.69	12.44
Property, Plant & Equipment	1.24	1.3	1.07	-	-	-
Long-Term Deferred Charges	1.89	1.89	1.89	1.89	1.89	1.89
Other Long-Term Assets	-0	-	-0	-	-	17.05
Total Assets	31.05	28.57	13.6	9.35	19.57	31.37
Accounts Payable	2.78	1.53	1.23	2.2	1.67	0.99
Accrued Expenses	1.39	0.84	0.95	1.23	0.97	1.17
Other Current Liabilities	3.41	6.91	2.77	0.27	0.16	0.07
Total Current Liabilities	7.57	9.28	4.95	3.69	2.8	2.22
Other Long-Term Liabilities	-0	-	-	-	-0	-0
Total Liabilities	7.57	9.28	4.95	3.69	2.8	2.22
Common Stock	1.64	1.48	1.23	1.16	1.03	0.84
Additional Paid-In Capital	99.55	89.72	68.89	64.86	59.39	52.49
Retained Earnings	-77.71	-71.91	-61.46	-60.36	-44.11	-24.73
Comprehensive Income & Other	-	-	-	0	0.47	0.56
Shareholders' Equity	23.49	19.29	8.66	5.66	16.78	29.15
Total Liabilities & Equity	31.05	28.57	13.6	9.35	19.57	31.37
Net Cash (Debt)	26.04	23.49	6.09	3.32	15.43	11.95
Net Cash Growth	373.39%	285.70%	83.49%	-78.50%	29.13%	1224.40%
Net Cash Per Share	-	1.42	0.39	0.25	1.32	1.17
Filing Date Shares Outstanding	-	18.63	15.35	14.46	12.91	11.57
Total Common Shares Outstanding	-	18.63	15.35	14.46	12.91	11.57
Working Capital	20.36	16.09	5.7	3.77	14.89	10.21
Book Value Per Share	-	1.04	0.56	0.39	1.30	2.52
Tangible Book Value	23.49	19.29	8.66	5.66	16.78	29.15
Tangible Book Value Per Share	-	1.04	0.56	0.39	1.30	2.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.